Theravance Biopharma Inc. (TBPH)
undefined
undefined%
At close: undefined

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12
Net Income -55.19M -92.82M -199.43M -278.02M -236.46M -215.52M -285.40M -190.67M -182.22M -237.04M -156.28M -9.57M
Depreciation & Amortization 4.26M 7.02M 9.71M 9.06M 6.21M 3.17M 4.03M 3.12M 2.99M 2.66M 2.65M 3.25M
Stock-Based Compensation 25.37M 39.73M 62.06M 62.98M 60.45M 51.31M 49.15M 41.17M 54.05M 43.23M 22.48M 21.32M
Other Working Capital -8.35M 46.68M -11.46M -26.72M -31.25M 55.85M 27.54M 65.27M -45.90M 15.57M 11.36M -125.24M
Other Non-Cash Items 3.70M -183.28M 3.86M -20.43M -23.01M -43.00K 10.00K 182.00K -8.06M 3.22M 20.00K 196.00K
Deferred Income Tax 3.21M - -44.48M 15.46M - -11.21M 8.74M 282.00K 2.17M - - -
Change in Working Capital -8.34M 42.35M -39.58M -39.46M -45.40M 59.43M 22.43M 46.93M -37.78M 12.77M 10.18M -134.30M
Operating Cash Flow -27.00M -186.99M -207.86M -250.40M -238.20M -112.87M -201.05M -98.99M -168.86M -175.16M -120.96M -119.11M
Capital Expenditures -2.49M -572.00K -3.41M -6.62M -3.18M -7.24M -2.41M -2.13M -2.65M -3.11M -2.73M -2.59M
Acquisitions - 4.58M 6.00K 64.00K 5.00M 20.00M - - - - - -
Purchase of Investments -134.53M -103.14M -158.31M -401.99M -423.90M -183.26M -288.79M -237.57M -73.01M -168.89M - -
Sales Maturities Of Investments 102.81M 158.02M 286.20M 419.26M 339.02M 347.19M 234.86M 91.47M 186.70M 66.44M - -
Other Investing Acitivies 1.51M 1.10B 127.90M 17.34M 5.00K 17.00K -53.93M -146.10M 113.69M -693.00K 100.00K 160.00K
Investing Cash Flow -32.70M 1.15B 124.49M 10.72M -83.05M 176.71M -56.33M -148.24M 111.04M -106.25M -2.63M -2.43M
Debt Repayment - -631.60M -10.73M 144.65M -2.15M 229.44M - 222.50M - - - -69.00K
Common Stock Repurchased -199.55M -132.28M -9.06M -9.75M -3.17M -9.81M -8.56M -3.87M -756.00K -178.00K - -
Dividend Paid - - - - - - - - - - - -
Other Financial Acitivies 618.00K 5.08M 3.47M -11.73M 3.44M 5.57M 10.22M 7.57M 3.05M 370.80M 123.59M 121.61M
Financial Cash Flow -198.93M -758.81M 91.86M 263.08M 1.29M 225.20M 1.66M 479.23M 81.31M 370.62M 123.59M 121.54M
Net Cash Flow -258.63M 208.21M 8.50M 23.40M -319.96M 289.04M -255.73M 232.00M 23.49M 370.62M - -
Free Cash Flow -29.48M -187.56M -211.26M -257.02M -241.37M -120.11M -203.46M -101.12M -171.50M -178.26M -123.69M -121.70M